EARNINGS AND TRADING: Scancell gets FDA clearance for phase 3 trial
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 0.225p on 20-02-2026 at 19:15:14 |
|---|---|
| Change | -0.01p -4.26% |
| Buy | 0.24p |
| Sell | 0.21p |
| Last Trade: | Unknown 4,700,000.00 at 0.212p |
| Day's Volume: | 4,838,620 |
| Last Close: | 0.225p |
| Open: | 0.235p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.225p - 0.235p |
| 52wk Range: | 0.18p - 0.30p |
| Market Capitalisation: | £4.84m |
| VWAP: | 0.21277p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 4,700,000 | 0.212p | Ordinary |
14:43:30 - 20-Feb-26 |
| Buy* | 100,000 | 0.236p | Ordinary |
11:57:33 - 20-Feb-26 |
| Buy* | 10,910 | 0.237p | Ordinary |
11:56:08 - 20-Feb-26 |
| Buy* | 5,232 | 0.25p | SI Trade |
11:12:01 - 20-Feb-26 |
| Buy* | 13,118 | 0.25p | Ordinary |
11:08:17 - 20-Feb-26 |
| Buy* | 1,360 | 0.25p | SI Trade |
11:08:17 - 20-Feb-26 |
| Buy* | 8,000 | 0.25p | SI Trade |
11:08:17 - 20-Feb-26 |
| Sell* | 1,000,000 | 0.22p | Ordinary |
16:17:32 - 19-Feb-26 |
| Sell* | 1,000,000 | 0.22p | Ordinary |
16:17:10 - 19-Feb-26 |
| Sell* | 1,000,000 | 0.223p | Ordinary |
16:16:49 - 19-Feb-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Jan 2026 7:00 am | RNS | Ox-1 Addiction Programme Update |
| 5th Jan 2026 7:00 am | RNS | Key Ox-1 milestone & notice of investor webinar |
| 18th Dec 2025 7:00 am | RNS-R | Potential of Preclinical Program in Mental Fatigue |
| 3rd Dec 2025 7:00 am | RNS | Half-year Financial Report |
| 26th Nov 2025 7:00 am | RNS-R | Marking Addiction Awareness Week |
| 24th Nov 2025 7:00 am | RNS | Notice of Results |
| 3rd Nov 2025 7:00 am | RNS | Ox-1 Programme Achieves Manufacturing Milestone |
| 16th Oct 2025 4:45 pm | RNS | Holding(s) in Company |
| 16th Oct 2025 4:45 pm | RNS | Director/PDMR Shareholding |
| 10th Oct 2025 7:00 am | RNS-R | World Mental Health Day & Q4 Conference Schedule |